i) information relating to Axis-Shield has been extracted or derived, without material adjustment, from public sources;

ii) all prices quoted for Axis-Shield Shares have been derived from SEDOL and represent the closing middle market prices of Axis-Shield Shares on the relevant dates;

iii) references to a percentage of Axis-Shield Shares are based on the number of Axis-Shield Shares in issue (as sourced from the Regulatory Information Service announcement released by Axis-Shield on 15 July 2011);

iv) the Offer Price premium calculations have been calculated by reference to the Closing Price of 335 pence per Axis-Shield Share on 5 July 2011, being the last Business Day prior to the commencement of the Offer Period;

v) figures stated are subject to rounding approximations;

vi) the three month weighted average share price is calculated using both share price and volume data from Bloomberg from 5 April 2011 to 5 July 2011; and

vii) Axis Shield's key industry peers being referred to for the indices statement include Abaxis Inc, Alere Inc, BioMerieux S.A., Bio-Rad Laboratories Inc, DiaSorin S.p.A, Immucor Inc, Immunodiagnostic Systems Holdings plc, IRIS International Inc, Meridian Bioscience Inc and Quidel Corp. Share prices have been recorded for the period from 6 July 2011 to 23 September 2011 and sourced from Bloomberg.

Further InformationThe Alere Directors and Alere AS Holdings Directors accept responsibility for t
'/>"/>